APA-referens

Liu, Q., Tong, D., Liu, G., Xu, J., Do, K., Geary, K., . . . Jiang, J. (2017). Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT. Cell Death Dis.

Chicago-stil citat

Liu, Qiuli, et al. "Metformin Reverses Prostate Cancer Resistance to Enzalutamide By Targeting TGF-β1/STAT3 Axis-regulated EMT." Cell Death Dis 2017.

MLA-referens

Liu, Qiuli, et al. "Metformin Reverses Prostate Cancer Resistance to Enzalutamide By Targeting TGF-β1/STAT3 Axis-regulated EMT." Cell Death Dis 2017.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.